The challenge of offering long-acting antipsychotic therapies: A preliminary discourse analysis of psychiatrist recommendations for injectable therapy to patients with schizophrenia

Journal of Clinical Psychiatry

Volumn 76, Issue 6, 2015, Pages 684-690

  Weiden, Peter J ^a   Roma, Rebecca S ^b   Velligan, Dawn I ^c   Alphs, Larry ^d   DiChiara, Matthew ^e   Davidson, Brad ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Texas Health Science Center   (United States)

^c Mercy Behavioral Health ^*  (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e Ogilvy Commonhealth Worldwide   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; DELAYED RELEASE FORMULATION;

ADULT; AMBIVALENCE; ARTICLE; CLINICAL ARTICLE; CONVERSATION; DISCOURSE ANALYSIS; DOCTOR PATIENT RELATION; ETHNOGRAPHIC RESEARCH; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MENTAL HEALTH CENTER; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT COUNSELING; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PSYCHIATRIST; SCHIZOPHRENIA; TREATMENT REFUSAL; UNITED STATES; ADMINISTRATION AND DOSAGE; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; MULTICENTER STUDY; THERAPEUTIC USE; VIDEORECORDING;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; PHYSICIAN-PATIENT RELATIONS; SCHIZOPHRENIA; UNITED STATES; VIDEOTAPE RECORDING;

EID: 84932598804     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08946     Document Type: Article

References (31)

1. Frongillo M, Feibelmann S, Belkora J, et al. Is there shared decision making when the provider makes a recommendation? Patient Educ Couns. 2013;90(1):69-73. doi:10.1016/j.pec.2012.08.016 PubMed
2. Gwyn R, Elwyn G. When is a shared decision not (quite) a shared decision? negotiating preferences in a general practice encounter. Soc Sci Med. 1999;49(4):437-447. doi:10.1016/S027-9536(9)067-2 PubMed
3. Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract suppl. 2009;63(164):6-10. doi:10.1111/j.1742-1241.2009.02176.x PubMed
4. Hamann J, Cohen R, Leucht S, et al. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry. 2005;162(12):2382-2384. doi:10.1176/appi.ajp.162.12.2382 PubMed
5. Hamann J, Cohen R, Leucht S, et al. Shared decision making and long-term outcome in schizophrenia treatment. J Clin Psychiatry. 2007;68(7):992-997. doi:10.4088/JCP.v68n0703 PubMed
6. Hamann J, Mendel RT, Fink B, et al. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment. J Nerv Ment Dis. 2008;196(4):329-332. doi:10.1097/NMD.0b013e31816a62a0 PubMed
7. McNeil BJ, Pauker SG, Sox HC Jr, et al. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306(21):1259-1262. doi:10.1056/NEJM198205273062103 PubMed
8. Ledford CJW, Villagran MM, Kreps GL, et al. "Practicing medicine": patient perceptions of physician communication and the process of prescription. Patient Educ Couns. 2010;80(3):384-392. doi:10.1016/j.pec.2010.06.033 PubMed
9. Velligan DI, Weiden PJ, Sajatovic M, et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J Psychiatr Pract. 2010;16(5):306-324. doi:10.1097/01.pra.0000388626.98662.a0 PubMed
10. Velligan DI, Lam F, Ereshefsky L, et al. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv. 2003;54(5):665-667. doi:10.1176/appi.ps.54.5.665 PubMed
11. Weiden PJ, Zygmunt A. Medication noncompliance in schizophrenia, part 1: assessment. J Pract Psychiatry Behav Health. 1997;3:106-110.
12. Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol. 1998;8(1):55-66. doi:10.1016/S0924-977X(97)00045-X PubMed
13. Lehman AF, Lieberman JA, Dixon LB, et al American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(suppl):1-56. PubMed
14. Velligan DI, Medellin E, Draper M, et al. Barriers to, and strategies for, starting a long acting injection clinic in a community mental health center. Community Ment Health J. 2011;47(6):654-659. doi:10.1007/s10597-011-9389-6 PubMed
15. Patel MX, de Zoysa N, Bernadt M, et al. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry. 2008;69(10):1548-1556. doi:10.4088/JCP.v69n1004 PubMed
16. Patel MX, DE Zoysa N, Baker D, et al. Antipsychotic depot medication and attitudes of community psychiatric nurses. J Psychiatr Ment Health Nurs. 2005;12(2):237-244. doi:10.1111/j.1365-2850.2004.00826.x PubMed
17. Patel MX, Haddad PM, Chaudhry IB, et al. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J Psychopharmacol. 2010;24(10):1473-1482. doi:10.1177/0269881109104882 PubMed
18. Heres S, Hamann J, Kissling W, et al. Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry. 2006;67(12):1948-1953. doi:10.4088/JCP.v67n1216 PubMed
19. Ainsworth-Vaughn N. Chapter 23, The discourse of medical encounters. In: Schiffrin D, Tannen D, Hamilton HE, eds. The Handbook of Discourse Analysis. Oxford, UK: Blackwell Publishing; 2001:453-469. doi:10.1111/b.9780631205968.2003.00024.x
20. Aranguri C, Davidson B, Ramirez R. Patterns of communication through interpreters: a detailed sociolinguistic analysis. J Gen Intern Med. 2006;21(6):623-629. doi:10.1111/j.1525-1497.2006.00451.x PubMed
21. Davidson B, Blum D, Cella D, et al. Communicating about chemotherapy-induced anemia. J Support Oncol. 2007;5(1):36-40, 46. PubMed
22. Hamilton HE, Nelson M, Martin P, et al. Provider-patient in-office discussions of response to hepatitis C antiviral therapy and impact on patient comprehension. Clin Gastroenterol Hepatol. 2006;4(4):507-513. doi:10.1016/j.cgh.2005.10.008 PubMed
23. Gumperz JJ. On interactional sociolinguistic method. In: Sarangi S, Roberts C, eds. Talk, Work and Institutional Order. Discourse in Medical, Mediation and Management Settings. Berlin, Germany: Mouton de Gruyter; 1999:453-472. doi:10.1515/9783110208375.4.453
24. Hamilton HE. Symptoms and signs in particular: the influence of the medical concern on the shape of physician-patient talk. Commun Med. 2004;1(1):59-70. doi:10.1515/come.2004.006 PubMed
25. Potkin S, Bera R, Zubek D, et al. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia. BMC Psychiatry. 2013;13(1):261. doi:10.1186/1471-244X-13-261 PubMed
26. Thibaut F. Acute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry guidelines. Psychiatr Danub. 2014;26(1):2-11. PubMed
27. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia: relationship to course and outcome. Arch Gen Psychiatry. 1990;47(3):228-236. doi:10.1001/archpsyc.1990.01810150028006 PubMed
28. Weiss KA, Smith TE, Hull JW, et al. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophr Bull. 2002;28(2):341-349. doi:10.1093/oxfordjournals.schbul.a006943 PubMed
29. Koenig CJ. Patient resistance as agency in treatment decisions. Soc Sci Med. 2011;72(7):1105-1114. doi:10.1016/j.socscimed.2011.02.010 PubMed
30. Gurmankin AD, Baron J, Hershey JC, et al. The role of physicians' recommendations in medical treatment decisions. Med Decis Making. 2002;22(3):262-271. PubMed
31. Ainsworth-Vaughn N. Claiming Power in Doctor-Patient Talk (Oxford Studies in Sociolinguistics). New York, NY: Oxford University Press; 1998:1.